Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.63 |
| ▸ | RAB9A | P51151 | 5/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 3/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.60 |
| ▸ | BCHE | P06276 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.59 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.59 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.57 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31725848 | 1.00 | NPC1 (0.63) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL31361425 | 0.94 | BCHE (0.60) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL3239903 | 0.94 | BCHE (0.60) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL584781 | 0.90 | SLC2A1 (0.56) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL30280404 | 0.90 | SLC2A1 (0.56) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL31040308 | 0.89 | NPC1 (0.52) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL30027542 | 0.89 | NPC1 (0.52) | NPC1RAB9APOLBMEN1KMT2A | |
| SCHEMBL1322956 | 0.88 | KDM4E (0.64) | NPC1RAB9AMEN1KMT2ABCHE | |
| SCHEMBL21377514 | 0.87 | NPC1 (0.63) | NPC1RAB9APOLBKDM4EAPP | |
| SCHEMBL6035606 | 0.86 | MEN1 (0.60) | NPC1RAB9APOLBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707647-A | Preparation method of dendrobe phenol | 安徽中医药大学 | 2025-03-28 | — | — | CN | claimed |
| CN-114773989-A | Anti-silver colloid diffusion agent, preparation method and application thereof | 苏州瑞港环保科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-20140142279-A1 | Method for peptide synthesis | LALEZARI IRAJ (US) | 2014-05-22 | — | — | US | claimed |
| US-6989052-B1 | Phase change ink printing process | XEROX CORPORATION (US) | 2006-01-24 | — | — | US | claimed |
| US-20060004123-A1 | PHASE CHANGE INK PRINTING PROCESS | XEROX CORPORATION | 2006-01-05 | — | — | US | claimed |
| CN-119707647-A | Preparation method of dendrobe phenol | 安徽中医药大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-119707647-A | Preparation method of dendrobe phenol | 安徽中医药大学 | 2025-03-28 | — | — | CN | disclosed |
| CN-118112898-A | Photoresist stripping liquid and application thereof | 芝普企业股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-112190571-B | Application of gastrodia tuber source derivative in preparing medicine for treating inflammatory bowel disease | 中国医学科学院药物研究所 | 2023-05-05 | — | — | CN | disclosed |
| CN-112190570-B | Application of gastrodia tuber source derivative in preparing medicine for treating acute or chronic pain | 中国医学科学院药物研究所 | 2023-05-05 | — | — | CN | disclosed |
| US-11505617-B2 | Benzodiazepine derivatives | IMMUNOGEN, INC. (US) | 2022-11-22 | — | — | US | disclosed |
| CN-114773989-A | Anti-silver colloid diffusion agent, preparation method and application thereof | 苏州瑞港环保科技有限公司 | 2022-07-22 | — | — | CN | disclosed |
| WO-2001047892-A1 | TRICYCLIC PROTEIN KINASE INHIBITORS | WYETH (US) | 2001-07-05 | — | — | WO | disclosed |
| EP-1112262-A1 | SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO | Inflazyme Pharmaceuticals, Ltd. (CA) | 2001-07-04 | — | — | EP | disclosed |
| US-6210816-B1 | Translucent xerographic recording substrates | XEROX CORPORATION | 2001-04-03 | — | — | US | disclosed |
| WO-2000014083-A1 | SUBSTITUTED η-PHENYL-Δ-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO | INFLAZYME PHARMACEUTICALS LTD. (CA) | 2000-03-16 | — | — | WO | disclosed |
| WO-1998040472-A2 | CARBOXYLIC ACID REDUCTASE, AND METHODS OF USING SAME | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1998-09-17 | — | — | WO | disclosed |
| US-5795759-A | Carboxylic acid reductase, and methods of using same | THE UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 1998-08-18 | — | — | US | disclosed |
| US-5622137-A | FOR USE IN TESTING COOKED FOODS | TRANS WORLD SERVICES (US) | 1997-04-22 | — | — | US | disclosed |
| EP-0613879-A1 | PHELLODENDRINE ANALOGS AND ALLERGY TYPE IV SUPPRESSOR CONTAINING THE SAME AS ACTIVE INGREDIENT | TSUMURA & CO. (JP) | 1994-09-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142279-A1 | Method for peptide synthesis | VIP, DNPEP, NGLY1 | NPC1 972/4885RAB9A 2875/4885POLB 3368/4885 |
| US-11505617-B2 | Benzodiazepine derivatives | GABBR1, GABRB1, GABRA1 | NPC1 1245/4885RAB9A 3800/4885POLB 2686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.